ProfileGDS5822 / ILMN_3162174
TitleAnti-CTLA-4 immunotherapy effect on αSMA+ myofibroblast late-depleted pancreatic ductal adenocarcinoma model
OrganismMus musculus


control myofibroblast depletion untreated anti-CTLA4 antibody GSM1276599 GSM1276600 GSM1276601 GSM1276602 GSM1276603 GSM1276604 GSM1303940 GSM1303941 GSM1303942 98% 97% 96% 98% 97% 97% 98% 97% 97% sort by protocol sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM1276599PDAC Late Ablation Control 12482.198
GSM1276600PDAC Late Ablation Control 21949.397
GSM1276601PDAC Late Ablation Control 31558.396
GSM1276602PDAC Late Ablation 13043.998
GSM1276603PDAC Late Ablation 21983.697
GSM1276604PDAC Late Ablation 32192.397
GSM1303940PDAC Late Ablation_anti-CTLA4 13366.698
GSM1303941PDAC Late Ablation_anti-CTLA4 22353.897
GSM1303942PDAC Late Ablation_anti-CTLA4 32243.997